Activated microglia in a rat stroke model express NG2 proteoglycan in peri-infarct tissue through the involvement of TGF-β1

GLIA

Volumn 62, Issue 2, 2014, Pages 185-198

  Sugimoto, Kana ^a   Nishioka, Ryutaro ^a   Ikeda, Airi ^a   Mise, Ayano ^a   Takahashi, Hisaaki ^a   Yano, Hajime ^a   Kumon, Yoshiaki ^a   Ohnishi, Takanori ^a   Tanaka, Junya ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD68; Microglia; NG2; Phagocytosis; Stroke; TGF ; TREM 2

Indexed keywords

CD68 ANTIGEN; MEMBRANE RECEPTOR; MESSENGER RNA; NG2 CHONDROITIN SULFATE PROTEOGLYCAN; PROTEOCHONDROITIN SULFATE; TRANSFORMING GROWTH FACTOR BETA1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; UNCLASSIFIED DRUG;

ACTIVATED MICROGLIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN TISSUE; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; MACROPHAGE; MALE; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

CD68; MICROGLIA; NG2; PHAGOCYTOSIS; STROKE; TGF-Β; TREM-2;

ANIMALS; ANTIGENS; DISEASE MODELS, ANIMAL; INFARCTION, MIDDLE CEREBRAL ARTERY; MACROPHAGES; MALE; MICROGLIA; PROTEOGLYCANS; RATS; RATS, WISTAR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STROKE; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84890152999     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22598     Document Type: Article

References (43)

1. Abutbul S, Shapiro J, Szaingurten-Solodkin I, Levy N, Carmy Y, Baron R, Jung S, Monsonego A. 2012. TGF-beta signaling through SMAD2/3 induces the quiescent microglial phenotype within the CNS environment. Glia 60:1160-1171.
2. Anderova M, Vorisek I, Pivonkova H, Benesova J, Vargova L, Cicanic M, Chvatal A, Sykova E. 2011. Cell death/proliferation and alterations in glial morphology contribute to changes in diffusivity in the rat hippocampus after hypoxia-ischemia. J Cereb Blood Flow Metab 31:894-907.
3. Burg MA, Nishiyama A, Stallcup WB. 1997. A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. Exp Cell Res 235:254-264.
4. Butt AM, Kiff J, Hubbard P, Berry M. 2002. Synantocytes: new functions for novel NG2 expressing glia. J Neurocytol 31:551-565.
5. Choudhury ME, Sugimoto K, Kubo M, Nagai M, Nomoto M, Takahashi H, Yano H, Tanaka J. 2011. A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats. Brain Behav 1:26-43.
6. Claus HL, Walberer M, Simard ML, Emig B, Muesken SM, Rueger MA, Fink GR, Schroeter M. 2013. NG2 and NG2-positive cells delineate focal cerebral infarct demarcation in rats. Neuropathology 33:30-38.
7. Damoiseaux JG, Dopp EA, Calame W, Chao D, MacPherson GG, Dijkstra CD. 1994. Rat macrophage lysosomal membrane antigen recognized by monoclonal antibody ED1. Immunology 83:140-147.
8. Dirnagl U, Iadecola C, Moskowitz MA. 1999. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci 22:391-397.
9. Donnan GA, Fisher M, Macleod M, Davis SM. 2008. Stroke. Lancet 371:1612-1623.
10. Fisher M. 1997. Characterizing the target of acute stroke therapy. Stroke 28:866-872.
11. Gao Q, Lu J, Huo Y, Baby N, Ling EA, Dheen ST. 2010. NG2, a member of chondroitin sulfate proteoglycans family mediates the inflammatory response of activated microglia. Neuroscience 165:386-394.
12. Ginsberg MD, Pulsinelli WA. 1994. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Ann Neurol 36:553-554.
13. Grako KA, Stallcup WB. 1995. Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor. Exp Cell Res 221:231-240.
14. Green SP, Cairns B, Rae J, Errett-Baroncini C, Hongo JA, Erickson RW, Curnutte JT. 2001. Induction of gp91-phox, a component of the phagocyte NADPH oxidase, in microglial cells during central nervous system inflammation. J Cereb Blood Flow Metab 21:374-384.
15. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. 2011. Physiology of microglia. Physiol Rev 91:461-553.
16. Kitamura Y, Inden M, Minamino H, Abe M, Takata K, Taniguchi T. 2010. The 6-hydroxydopamine-induced nigrostriatal neurodegeneration produces microglia-like NG2 glial cells in the rat substantia nigra. Glia 58:1686-1700.
17. Kreutzberg GW. 1996. Microglia: A sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
18. Krupinski J, Kumar P, Kumar S, Kaluza J. 1996. Increased expression of TGF-β1 in brain tissue after ischemic stroke in humans. Stroke 27:852-857.
19. Kucharova K, Chang Y, Boor A, Yong VW, Stallcup WB. 2011. Reduced inflammation accompanies diminished myelin damage and repair in the NG2 null mouse spinal cord. J Neuroinflammation 8:158.
20. Kurpius D, Nolley EP, Dailey ME. 2007. Purines induce directed migration and rapid homing of microglia to injured pyramidal neurons in developing hippocampus. Glia 55:873-884.
21. Lin XH, Dahlin-Huppe K, Stallcup WB. 1996. Interaction of the NG2 proteoglycan with the actin cytoskeleton. J Cell Biochem 63:463-477.
22. Ma M, Ma Y, Yi X, Guo R, Zhu W, Fan X, Xu G, Frey WH, Liu X. 2008. Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone. BMC Neurosci 9:117.
23. Matsumoto H, Kumon Y, Watanabe H, Ohnishi T, Shudou M, Chuai M, Imai Y, Takahashi H, Tanaka J. 2008. Accumulation of macrophage-like cells expressing NG2 proteoglycan and Iba1 in ischemic core of rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 28:149-163.
24. Matsumoto H, Kumon Y, Watanabe H, Ohnishi T, Shudou M, Ii C, Takahashi H, Imai Y, Tanaka J. 2007. Antibodies to CD11b, CD68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions. J Neurosci Res 85:994-1009.
25. Moransard M, Dann A, Staszewski O, Fontana A, Prinz M, Suter T. 2011. NG2 expressed by macrophages and oligodendrocyte precursor cells is dispensable in experimental autoimmune encephalomyelitis. Brain 134:1315-1330.
26. Nishihara T, Ochi M, Sugimoto K, Takahashi H, Yano H, Kumon Y, Ohnishi T, Tanaka J. 2011. Subcutaneous injection containing IL-3 and GM-CSF ameliorates stab wound-induced brain injury in rats. Exp Neurol 229:507-516.
27. Nishiyama A, Watanabe M, Yang Z, Bu J. 2002. Identity, distribution, and development of polydendrocytes: NG2-expressing glial cells. J Neurocytol 31:437-455.
28. Pal G, Vincze C, Renner E, Wappler EA, Nagy Z, Lovas G, Dobolyi A. 2012. Time course, distribution and cell types of induction of transforming growth factor βs following middle cerebral artery occlusion in the rat brain. PLoS One 7:e46731.
29. Patel AR, Ritzel R, McCullough LD, Liu F. 2013. Microglia and ischemic stroke: A double-edged sword. Int J Physiol Pathophysiol Pharmacol 5:73-90.
30. Ruocco A, Nicole O, Docagne F, Ali C, Chazalviel L, Komesli S, Yablonsky F, Roussel S, MacKenzie ET, Vivien D, Buisson A. 1999. A transforming growth factor-β antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury. J Cereb Blood Flow Metab 19:1345-1353.
31. Sieber MW, Jaenisch N, Brehm M, Guenther M, Linnartz-Gerlach B, Neumann H, Witte OW, Frahm C. 2013. Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke. PLoS One 8:e52982.
32. +macrophage-like cells expressing a variety of neuroprotective factors ameliorate ischemic damage of the brain. J Cereb Blood Flow Metab 30:603-615.
33. Stallcup WB. 2002. The NG2 proteoglycan: Past insights and future prospects. J Neurocytol 31:423-435.
34. Suzumura A, Sawada M, Yamamoto H, Marunouchi T. 1993. Transforming growth factor-beta suppresses activation and proliferation of microglia in vitro. J Immunol 151:2150-2158.
35. Takahashi H, Matsumoto H, Smirkin A, Itai T, Nishimura Y, Tanaka J. 2008. Involvement of heparanase in migration of microglial cells. Biochim Biophys Acta 1780:709-715.
36. Tanaka J, Toku K, Matsuda S, Sudo S, Fujita H, Sakanaka M, Maeda N. 1998. Induction of resting microglia in culture medium devoid of glycine and serine. Glia 24:198-215.
37. Tanaka J, Toku K, Zhang B, Ishihara K, Sakanaka M, Maeda N. 1999. Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species. Glia 28:85-96.
38. Tanaka K, Nogawa S, Ito D, Suzuki S, Dembo T, Kosakai A, Fukuuchi Y. 2001. Activation of NG2-positive oligodendrocyte progenitor cells during post-ischemic reperfusion in the rat brain. Neuroreport 12:2169-2174.
39. Tei N, Tanaka J, Sugimoto K, Nishihara T, Nishioka R, Takahashi H, Yano H, Matsumoto S, Ohue S, Watanabe H, Kumon Y, Ohnishi T. 2013. Expression of MCP-1 and fractalkine on endothelial cells and astrocytes may contribute to the invasion and migration of brain macrophages in ischemic rat brain lesions. J Neurosci Res 91:681-693.
40. Tillet E, Gential B, Garrone R, Stallcup WB. 2002. NG2 proteoglycan mediates beta1 integrin-independent cell adhesion and spreading on collagen VI. J Cell Biochem 86:726-736.
41. Wohl SG, Schmeer CW, Friese T, Witte OW, Isenmann S. 2011. In situ dividing and phagocytosing retinal microglia express nestin, vimentin, and NG2 in vivo. PLoS One 6:e22408.
42. Yokoyama A, Sakamoto A, Kameda K, Imai Y, Tanaka J. 2006. NG2 proteoglycan-expressing microglia as multipotent neural progenitors in normal and pathologic brains. Glia 53:754-768.
43. Zhu L, Lu J, Tay SS, Jiang H, He BP. 2010. Induced NG2 expressing microglia in the facial motor nucleus after facial nerve axotomy. Neuroscience 166:842-851.